Self-report data as a tool for subtype identification in genetically-defined Parkinson's Disease

Scientific Reports
Ashley R WinslowWarren D Hirst

Abstract

Through a targeted recruitment 23andMe has collected DNA and patient-reported symptoms from more than 10,000 subjects reporting a physician-verified diagnosis of PD. This study evaluated the potential of self-report, web-based questionnaires to rapidly assess disease natural history and symptomology in genetically-defined PD populations. While average age-at-diagnosis was significantly lower in GBA mutation carriers compared to idiopathic PD, or iPD (idiopathic PD, defined as no GBA mutations and no LRRK2 G2019S mutation), there were no significant differences in symptoms. Conversely, LRRK2 G2019S carrier status significantly associated with reporting of milder daily symptoms of lightheadedness and several differences were observed at a false discovery rate < 0.1, including increased reporting of changes in walking as an initial symptom of disease, decreased reporting of lightheadedness upon standing, and milder symptoms related to daily functioning. The subclinical differences in symptoms reported by LRRK2 G2019S carriers suggest differences in underlying pathophysiology and/or disease progression in LRRK2 carriers compared to iPD. Importantly, we confirm previous findings in PD genetic subsets where disease characteristics we...Continue Reading

References

Sep 1, 1996·QJM : Monthly Journal of the Association of Physicians·O NeudorferA Zimran
Jan 20, 2004·Molecular Genetics and Metabolism·Alicia LwinEllen Sidransky
Nov 5, 2005·Proceedings of the National Academy of Sciences of the United States of America·Andrew B WestTed M Dawson
Jun 10, 2008·Lancet Neurology·Daniel G HealyUNKNOWN International LRRK2 Consortium
Oct 23, 2009·The New England Journal of Medicine·E SidranskyS G Ziegler
Dec 17, 2009·Archives of Neurology·Roy N AlcalayKaren S Marder
Jun 30, 2010·PLoS Genetics·Nicholas ErikssonJoanna Mountain
Feb 1, 2011·Annals of Neurology·Anat MirelmanJeffrey M Hausdorff
Jan 28, 2012·Neurology·M AnheimUNKNOWN French Parkinson Disease Genetic Group
Apr 12, 2012·PloS One·Nicholas ErikssonChuong B Do
Oct 15, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Anat MirelmanUNKNOWN LRRK2 Ashkenazi Jewish Consortium
Nov 19, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Roy N AlcalayKaren S Marder
Aug 30, 2014·Neurologia i neurochirurgia polska·Michalina Malec-LitwinowiczAndrzej Szczudlik
Feb 6, 2015·Neurology·Ziv Gan-OrAvi Orr-Urtreger
May 13, 2015·Parkinsonism & Related Disorders·Ziv Gan-OrGuy A Rouleau
Jun 24, 2017·Movement Disorders : Official Journal of the Movement Disorder Society·Annie J LeeUNKNOWN Michael J. Fox LRRK2 Cohort Consortium
Oct 11, 2017·Journal of the Neurological Sciences·Camilla P da SilvaMárcia M G Pimentel

❮ Previous
Next ❯

Methods Mentioned

BETA
MDS
genotyping

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Parkinsonism & Related Disorders
Beatriz TijeroJuan José Zarranz
Movement Disorders : Official Journal of the Movement Disorder Society
Avner ThalerAnat Mirelman
Annals of Clinical and Translational Neurology
Rachel Saunders-PullmanSusan B Bressman
© 2022 Meta ULC. All rights reserved